Control of Heterologous Hepatitis C Virus Infection in Chimpanzees Is Associated with the Quality of Vaccine-Induced Peripheral T-Helper Immune Response

Prophylactic hepatitis C virus (HCV) vaccine trials with human volunteers are pending. There is an important need for immunological end points which correlate with vaccine efficacy and which do not involve invasive procedures, such as liver biopsies. By using a multicomponent DNA priming-protein boo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Virol
Autori principali: Rollier, C., Depla, E., Drexhage, J. A. R., Verschoor, E. J., Verstrepen, B. E., Fatmi, A., Brinster, C., Fournillier, A., Whelan, J. A., Whelan, M., Jacobs, D., Maertens, G., Inchauspé, G., Heeney, J. L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology (ASM) 2004
Soggetti:
Vaccines and Antiviral Agents
Accesso online:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC303385/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14671100/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.1.187-196.2004
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi